secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001193125-23-137263
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD enters $5M private placement with Rubric Capital
---------------------------------------------------------------

- Agreement to sell up to 5M shares at volume-weighted average price, aggregate up to $5M.
- Initial drawdown of 312,525 shares at $3.6797/share upon stockholder approval.
- Stockholders must approve the private placement at the upcoming annual meeting.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312523137263/0001193125-23-137263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312523137263/d440805d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-137263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer